Ozgür Yüksekdag (Ozgur Yuksekdag, Ozgür Yuksekdag)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Top Venues

Molecular biology reports

Indian journal of orthopaedics

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ismail Koyuncu, Ebru Temiz, Behice Hande Sisman, Mustafa Durgun, Ozgür Yüksekdag, Simone Giovannuzzi, Claudiu T Supuran
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem (2024)
Ismail Koyuncu, Ebru Temiz, Behice Hande Sisman, Mustafa Durgun, Ozgür Yüksekdag, Simone Giovannuzzi, Claudiu T Supuran
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem 19 (9) (2024)
Ismail Koyuncu, Ebru Temiz, Behice Hande Sisman, Mustafa Durgun, Ozgür Yüksekdag, Simone Giovannuzzi, Claudiu T Supuran
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem 19 (9) (2024)
Ebru Temiz, Kadir Eği, Ismail Koyuncu, Ozgür Yüksekdag, Yusuf Kurt, Murat Tiken, Sukru Akmese
Cedrus libani tar prompts reactive oxygen species toxicity and DNA damage in colon cancer cells. Molecular biology reports 49 (8) (2022)
Evren Gumus, Ebru Temiz, Baran Sarıkaya, Ozgür Yüksekdag, Serkan Sipahioglu, Ataman Gonel
The Association Between BMP-2, UQCC1 and CX3CR1 Polymorphisms and the Risk of Developmental Dysplasia of the Hip. Indian journal of orthopaedics 55 (1) (2020)
Ismail Koyuncu, Ataman Gonel, Mustafa Durgun, Abdurrahim Koçyiğit, Ozgür Yüksekdag, Claudiu T Supuran
Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2018)